ImmunityBio Inc.

3.50
-0.14 (-3.85%)
At close: Feb 21, 2025, 3:46 PM

ImmunityBio Inc. Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for IBRX stock have an median target of 18, with a low estimate of 4.75 and a high estimate of 30. The median target predicts an increase of 414.29% from the current stock price of 3.50.

Analyst Consensus: Buy
Target Low Average Median High
Price $4.75 $17.69 $18 $30
Change 35.71% 405.43% 414.29% 757.14%

AI Analyst Report

D. Boral Capital has reaffirmed a Buy rating for I... Unlock content with Pro Subscription

Updated Feb 19, 2025

Rating Aug 24Oct 24Nov 24Dec 24Jan 25Feb 25
Strong Buy 000000
Buy 013152
Hold 100000
Sell 000000
Strong Sell 000000
Total 1 1 3 1 5 2

Financial Forecast this Year

Revenue This Year
21.23M
from 622K
Increased by 3.31K%
Revenue Next Year
136.22M
from 21.23M
Increased by 541.8%
EPS This Year
-0.8
from -1.15
Increased by 30.4%
EPS Next Year
-0.67
from -0.8
Increased by 16.2%